Functional studies of chronic lymphocytic leukemia B cells expressing β 2 -integrin type complement receptors CR3 and CR4-Reference-Cited by-同舟云学术

Functional studies of chronic lymphocytic leukemia B cells expressing β 2 -integrin type complement receptors CR3 and CR4

Published:2017-09 Issue: Volume:189 Page:73-81
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Uzonyi Barbara,Mácsik-Valent Bernadett,Lukácsi Szilvia,Kiss Richárd,Török Katalin,Kremlitzka Mariann,Bajtay Zsuzsa,Demeter Judit,Bödör Csaba,Erdei Anna

Funder

Hungarian Academy of Sciences

Hungarian Science Fund (OTKA)

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Getting to the site of inflammation: the leukocyte adhesion cascade updated;Ley;Nat. Rev. Immunol.,2007

2. CD11c/CD18 dominates adhesion of human monocytes, macrophages and dendritic cells over CD11b/CD18;Sandor;PLoS One,2016

3. CR3 is the dominant phagocytotic complement receptor on human dendritic cells;Sandor;Immunobiology,2013

4. Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18;Postigo;J. Exp. Med.,1991

5. CD11b-mediated migratory property of peripheral blood B cells;Kawai;J. Allergy Clin. Immunol.,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrins in Health and Disease—Suitable Targets for Treatment?;Cells;2024-01-23

2. The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia;Cancers;2023-10-26

3. New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4;Immunology Letters;2021-09

4. BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1;PLOS ONE;2021-07-20

5. Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation;Frontiers in Immunology;2020-09-29